MK-0429,227963-15-7

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

MK-0429

CAS No. : 227963-15-7

MCE 国际站：MK-0429

产品活性：MK-0429 (L-000845704) 是可口服，高效，选择性，非多肽整合素泛拮抗剂，对αvβ1、αvβ3、αvβ5、αvβ6、αvβ8 和 α5β1 的 IC_{5 0} 值分别为1.6 nM、2.8 nM、0.1 nM、0.7 nM、0.5 nM 和 12.2 nM。

研究领域：Cytoskeleton

作用靶点：Integrin

In Vivo: MK-0429 (100 or 300 mg/kg, p.o., twice daily b.i.d., 2 weeks) reduces metastatic tumor colony formation and area in the lungs. MK-0429 is safe and efficacious in significantly decreasing melanoma metastasis in the lungs.

相关产品：Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Anti-Cancer Compound Library  |  Cytoskeleton Compound Library  |  Orally Active Compound Library  |  Targeted Diversity Library  |  Heterocyclic Compound Library  |  Membrane Protein-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Cilengitide  |  Cyclo(-RGDfK)  |  GLPG0187  |  Cucurbitacin B  |  E7820  |  CWHM-12  |  ATN-161 trifluoroacetate salt  |  Lifitegrast  |  Pyrintegrin  |  Arg-Gly-Asp-Ser  |  GPRP acetate  |  Tirofiban  |  Fibronectin  |  Carotegrast methyl  |  αvβ1 integrin-IN-1 TFA  |  iRGD peptide  |  Bexotegrast  |  A-205804  |  Eptifibatide  |  RGD peptide (GRGDNP) (TFA)  |  Vedolizumab  |  Natalizumab  |  Tetrac  |  Firategrast  |  Leukadherin-1  |  OSU-T315  |  Cyclo(RGDyK) trifluoroacetate  |  Etrolizumab

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds